Literature DB >> 24972658

Different compositions of pharmaceuticals in Dutch and Belgian rivers explained by consumption patterns and treatment efficiency.

Thomas L ter Laak1, Pascal J F Kooij, Harry Tolkamp, Jan Hofman.   

Abstract

In the current study, 43 pharmaceuticals and 18 transformation products were studied in the river Meuse at the Belgian-Dutch border and four tributaries of the river Meuse in the southern part of the Netherlands. The tributaries originate from Belgian, Dutch and mixed Dutch and Belgian catchments. In total, 23 pharmaceuticals and 13 transformation products were observed in samples of river water collected from these rivers. Observed summed concentrations of pharmaceuticals and transformation products in river water ranged from 3.5 to 37.8 μg/L. Metformin and its transformation product guanylurea contributed with 53 to 80 % to this concentration, illustrating its importance on a mass basis. Data on the flow rate of different rivers and demographics of the catchments enabled us to calculate daily per capita loads of pharmaceuticals and transformation products. These loads were linked to sales data of pharmaceuticals in the catchment. Simple mass balance modelling accounting for human excretion and removal by sewage treatment plants revealed that sales could predict actual loads within a factor of 3 for most pharmaceuticals. Rivers that originated from Belgian and mixed Dutch and Belgian catchments revealed significantly higher per capita loads of pharmaceuticals (16.0 ± 2.3 and 15.7 ± 2.1 mg/inhabitant/day, respectively) than the Dutch catchment (8.7 ± 1.8 mg/inhabitant/day). Furthermore, the guanylurea/metformin ratio was significantly lower in waters originating from Belgium (and France) than in those from the Netherlands, illustrating that sewage treatment in the Belgian catchment is less efficient in transforming metformin into guanylurea. In summary, the current study shows that consumption-based modelling is suitable to predict environmental loads and concentrations. Furthermore, different consumption patterns and wastewater treatment efficiency are clearly reflected in the occurrence and loads of pharmaceuticals in regional rivers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24972658     DOI: 10.1007/s11356-014-3233-9

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  39 in total

1.  Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data.

Authors:  Thomas Heberer
Journal:  Toxicol Lett       Date:  2002-05-10       Impact factor: 4.372

2.  Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy.

Authors:  Sara Castiglioni; Roberto Fanelli; Davide Calamari; Renzo Bagnati; Ettore Zuccato
Journal:  Regul Toxicol Pharmacol       Date:  2004-02       Impact factor: 3.271

3.  Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.

Authors:  C Miège; J M Choubert; L Ribeiro; M Eusèbe; M Coquery
Journal:  Environ Pollut       Date:  2009-02-06       Impact factor: 8.071

4.  Fate of beta blockers and psycho-active drugs in conventional wastewater treatment.

Authors:  Arne Wick; Guido Fink; Adriano Joss; Hansruedi Siegrist; Thomas A Ternes
Journal:  Water Res       Date:  2008-12-03       Impact factor: 11.236

5.  Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review.

Authors:  Kathryn M Onesios; Jim T Yu; Edward J Bouwer
Journal:  Biodegradation       Date:  2008-12-28       Impact factor: 3.909

Review 6.  Occurrence and fate of human pharmaceuticals in the environment.

Authors:  Sara C Monteiro; Alistair B A Boxall
Journal:  Rev Environ Contam Toxicol       Date:  2010       Impact factor: 7.563

7.  Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination.

Authors:  N G Grubb; D W Rudy; D C Brater; S D Hall
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 8.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

9.  Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation.

Authors:  Roberto Rosal; Antonio Rodríguez; José Antonio Perdigón-Melón; Alice Petre; Eloy García-Calvo; María José Gómez; Ana Agüera; Amadeo R Fernández-Alba
Journal:  Water Res       Date:  2009-07-09       Impact factor: 11.236

10.  [Biotransformation of tramadol in man and animal (author's transl)].

Authors:  W Lintz; S Erlaçin; E Frankus; H Uragg
Journal:  Arzneimittelforschung       Date:  1981
View more
  2 in total

1.  Do concentrations of pharmaceuticals in sewage reflect prescription figures?

Authors:  Alexander L N van Nuijs; Adrian Covaci; Herman Beyers; Lieven Bervoets; Ronny Blust; Gert Verpooten; Hugo Neels; Philippe G Jorens
Journal:  Environ Sci Pollut Res Int       Date:  2015-01-13       Impact factor: 4.223

2.  Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities.

Authors:  Jose Antonio Baz-Lomba; Stefania Salvatore; Emma Gracia-Lor; Richard Bade; Sara Castiglioni; Erika Castrignanò; Ana Causanilles; Felix Hernandez; Barbara Kasprzyk-Hordern; Juliet Kinyua; Ann-Kathrin McCall; Alexander van Nuijs; Christoph Ort; Benedek G Plósz; Pedram Ramin; Malcolm Reid; Nikolaos I Rousis; Yeonsuk Ryu; Pim de Voogt; Jorgen Bramness; Kevin Thomas
Journal:  BMC Public Health       Date:  2016-10-01       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.